ArticleJMIR medical informatics2025
Survival Prediction for Postoperative Patients With Kidney Cancer Based on Computed Tomography Radiomics: Retrospective Cohort Study.
Article in JMIR medical informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Noninvasive Preoperative Stratification of Renal Tumors for Aggressiveness and Prognosis.Bioengineering (Basel, Switzerland) · 2026Article
- Review
- Study on the prediction of postoperative metastasis in renal cancer using perirenal fat CT radiomics combined with clinical features.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Kidney cancer remains a significant challenge in oncology, with accurate prognostic assessment being crucial for postoperative management. While radiomics has shown promise in cancer prognosis, there is limited research on comprehensive models that effectively integrate radiomic features with clinical parameters for kidney cancer survival prediction. Objective: This study aimed to develop and validate a comprehensive computed tomography (CT) radiomics-based nomogram for predicting overall survival in postoperative patients with kidney cancer by integrating radiomic features with clinical parameters. Methods: Radiomic features were extracted from regions of interest in CT images of 207 postoperative patients with kidney cancer. The eigenvalue data of all radiomic features were processed using z score standardization and the R software package GLMNet. We integrated survival time, survival status, and radiomic features and screened these features using the least absolute shrinkage and selection operator-Cox regression method. We conducted 10-fold cross-validation to obtain an optimal model of 5 radiomic features. Multivariate Cox regression hazard models were established to analyze patients' overall survival. The predictive ability of the nomogram (receiver operating characteristic curve and calibration curve) was evaluated using bootstrap resampling validation. Patients were divided into high- and low-risk groups based on the radiomic risk score cutoff value, and the Kaplan-Meier method was conducted to identify established models' forecasting ability. Five radiomic features were screened for predictive model construction. Results: This retrospective analysis was conducted from April 2024 to July 2024 using data from The Cancer Imaging Archive public database. The final cohort included 207 patients (3 excluded from the initial 210) who underwent nephrectomy for kidney cancer. The median follow-up time was 33 (IQR 11-47) months. The receiver operating characteristic curve and area under the curve showed that the predictive model performed well. The calibration curve of nomogram and radiomic features in the cohort study set indicated an overall net benefit. Kaplan-Meier curves indicated that overall survival time was dramatically shorter in the high-risk group. Conclusions: Our radiomics nomogram successfully integrates CT-derived radiomic features with clinical variables for kidney cancer survival prediction, demonstrating good prognostic capability and offering a noninvasive, quantitative tool for personalized postoperative management and clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.